pharma · Relapsed or Refractory Multiple Myeloma (RRMM) · Relapsed and/or Refractory Multiple Myeloma
Celgene
Celgene Europe Limited
Celgene clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Summit, USA
- Employees
- 2,104
- Programs
- 45
- Drugs
- 91
- Patents
- 0
Celgene projects
9 ClinicalTrials.gov programs sponsored by Celgene.
Celgene has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CA059-001
Celgene Europe Limited
Acute Myeloid Leukemia and Myelodysplastic Syndromes
1 trial -
CA061-1001
Celgene Europe Limited
Systemic Sclerosis, Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathy, Systemic Lupus Erythematosus (SLE)
1 trial -
CA061-1006
Celgene Europe Limited
Myasthenia gravis (MG), Progressive Multiple Sclerosis (PMS), Relapsing Multiple Sclerosis (RMS)
1 trial -
CA1190002
Celgene Europe Limited
Relapsed and/or Refractory Multiple Myeloma
1 trial -
CC-486
Celgene Europe Limited
Leukemia, Myeloid, Acute
1 trial -
CC-90010-GBM-002
Celgene Europe Limited
Subjects with newly diagnosed WHO Grade IV glioblastoma (ndGBM) who have undergone complete or partial tumor resection
1 trial -
CC-90010-ST-001
Celgene Europe Limited
Part C: advanced or unresectable STs (Spain only), Part B : r/r diffuse large B cell lymphoma (DLBCL) (Cohort 1), advanced basal cell carcinoma (BCC) (Cohort 2), r/r DLBCL under an alternative dosing regimen (Cohort 3), Part A: advanced or unresectable solid tumors (STs) and relapsed and/or refractory (r/r) advanced non-Hodgkin's lymphomas (NHLs)
1 trial -
CC-90011-SCLC-001
Celgene Europe Limited
extensive stage small cell lung cancer
1 trial -
pomalidomide
Celgene Europe Limited
Multiple Myeloma in Relapse
1 trial
Frequently asked questions
How many clinical projects does Celgene have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.